Related Experiment Video
Updated: May 14, 2026
11:17
Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
Published on: February 27, 2026
Thoracoscopic lung metastasectomies: a 10-year, single-center experience
Felice Lo Faso1, Luciano Solaini, Rosalba Lembo
1Thoracic Surgery Unit, ASL Ravenna, Maria Cecilia Hospital, Via Corriera 1, 48010, Cotignola, Ravenna, Italy. felice_lo_faso@yahoo.com
Surgical Endoscopy
|January 25, 2013
Summary
Thoracoscopic surgery for pulmonary metastasectomy is safe and effective, offering survival rates comparable to open surgery. This minimally invasive approach is a valid option for lung cancer treatment.
Area of Science:
- Thoracic Surgery
- Surgical Oncology
- Minimally Invasive Procedures
Background:
- The optimal surgical management for pulmonary metastasectomy is debated.
- Minimally invasive techniques may improve quality of life without compromising oncologic outcomes.
Purpose of the Study:
- To validate the efficacy and safety of the thoracoscopic approach for pulmonary metastasectomy.
Main Methods:
- Retrospective review of 164 patients undergoing 212 lung metastasectomies (2000-2010).
- Analysis included complete curative resections, various tumor types, disease-free interval, and surgical techniques (VATS lobectomy, pneumonectomy, wedge resection).
- Lymph node sampling was performed in 117 cases.
Main Results:
- A mean follow-up of 38 months revealed 53% mortality.
- All resection margins were tumor-free.
- Multivariate analysis indicated no statistically significant influence of histologic type, disease-free interval, age, or number of metastases on long-term survival.
Conclusions:
- Thoracoscopic surgery is a safe and effective procedure for pulmonary metastasectomy.
- The 5-year survival rates are equivalent to those of open surgery.
- This approach is an acceptable alternative for patients requiring lung metastasis resection.
